Antignani Antonella, Youle Richard J
Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 35 Convent Drive MSC 3704, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8020-5. doi: 10.1073/pnas.0711707105. Epub 2008 Jun 6.
Endosomal cargo travels through a dynamic vesicle network en route to degradation by lysosomes or recycling through the Golgi apparatus back to the cell surface. Rab5 is a key determinant of the early endosomes by organizing effector proteins in specific subdomains and mediating early endosome fusion. We find that early endosome morphogenesis and maturation is disrupted by diphtheria toxin (DT). Rab5 bound endosomes increase in size and in Rab5 content due to luminal toxin exposure, whereas Rab7 positive endosomes are not detectably altered. These changes appear to be caused by an activity of the toxin entry domain (T domain) as mutations inactivating either the receptor binding (CRM107) or ADP-ribosyl transferase (CRM197) activities do not inhibit the effect of DT on endosome morphogenesis. In contrast, mutations in the T domain or diminishing the endosomal pH gradient, which prevents T domain membrane insertion, inhibit these endosome changes. The change in size appears to be due to changing the early endosome fission-fusion equilibrium. The Rab5 membrane exchange rate, assessed with photoactivatable GFP-Rab5, decreases in the presence of DT. These changes to endosomes may reflect activities of the T domain that mediate toxin entry to the cytosol. The nontoxic mutant DT, CRM197, yields a new tool to manipulate endosome dynamics in living cells.
内体货物在前往溶酶体降解或通过高尔基体循环回到细胞表面的途中,会穿过一个动态的囊泡网络。Rab5通过在特定亚结构域中组织效应蛋白并介导早期内体融合,成为早期内体的关键决定因素。我们发现,白喉毒素(DT)会破坏早期内体的形态发生和成熟。由于腔内毒素暴露,与Rab5结合的内体在大小和Rab5含量上都会增加,而Rab7阳性内体则没有明显变化。这些变化似乎是由毒素进入结构域(T结构域)的活性引起的,因为使受体结合(CRM107)或ADP-核糖基转移酶(CRM197)活性失活的突变并不会抑制DT对内体形态发生的影响。相比之下,T结构域的突变或降低内体pH梯度(这会阻止T结构域插入膜中)会抑制这些内体变化。大小的变化似乎是由于改变了早期内体的裂变-融合平衡。用可光激活的GFP-Rab5评估的Rab5膜交换率在DT存在时会降低。内体的这些变化可能反映了介导毒素进入细胞质的T结构域的活性。无毒突变体DT,即CRM197,为在活细胞中操纵内体动力学提供了一种新工具。